Gastric carcinoma in China: Current status and future perspectives (Review) - Wikidata - awgldk - TriplyDB

Gastric carcinoma in China: Current status and future perspectives (Review)

Gastric carcinoma in China: Current status and future perspectives (Review)

http://www.wikidata.org/entity/Q36216823

about

Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy Role of epithelial-mesenchymal transition in gastric cancer initiation and progression Serum IL-33 level is a predictor of progression-free survival after chemotherapy.Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population.Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.Prognostic value of decreased expression of RBM4 in human gastric cancer EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice.Andrographolide Inhibits Proliferation and Metastasis of SGC7901 Gastric Cancer Cells.Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer.Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer.Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only.

P2860

Q28541628-35D820E3-6B46-4FCE-9113-D986D96B7AC1 Q33594912-FD20056D-86E6-420C-ACC7-F77B1B980C9C Q33798754-B8E45906-FD75-499F-9C41-F94663F11C3A Q35022599-E07D1511-4E9D-42F4-A683-9080FC6BADEC Q35067928-77E6BA4D-EC39-4E02-8382-31C5A89C96AB Q36375129-B6186304-BFED-4D82-86A3-A49A8EBCF09A Q37024168-E13E6330-F4F6-4E78-AE05-0CAD1384724A Q37132959-D412DAA5-ACBB-41E7-8BBA-C635D0ED16CA Q37618362-6F01DEEC-8491-4F90-967A-E0AFE4A0316A Q38825491-60A19A23-C5AF-4259-9A20-98F4ED36A718 Q47111361-E379B249-5653-4979-B4CD-495E925FBE64 Q55303285-50602D42-43B4-4A55-B9D6-A4C93DCCF777

P2860

Gastric carcinoma in China: Current status and future perspectives (Review)

http://www.wikidata.org/entity/Q36216823

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Gastric carcinoma in China: Current status and future perspectives (Review)

@ast

Gastric carcinoma in China: Current status and future perspectives (Review)

@en

type

label

Gastric carcinoma in China: Current status and future perspectives (Review)

@ast

Gastric carcinoma in China: Current status and future perspectives (Review)

@en

prefLabel

Gastric carcinoma in China: Current status and future perspectives (Review)

@ast

Gastric carcinoma in China: Current status and future perspectives (Review)

@en

P1433

Q36216823-8566ECA2-0C93-4722-9A43-9289F849A861

P1476

Q36216823-EB43B80B-A055-454C-B340-7A6B410577B0

P2093

Q36216823-4EED90E7-F046-4A51-99C1-463CAD26D858

Q36216823-897F671E-C7F8-4848-AD3D-B706EE64427D

P2860

Q36216823-0AF1AF12-5B7B-4F9C-A835-6EF82FBA94B9

Q36216823-10184F14-C912-46A4-B082-FA54828B4BE1

Q36216823-1373C259-BDEE-41E2-9904-ED7A7CBD9F81

Q36216823-2E935644-8C83-4794-941C-57AB247C53F6

Q36216823-3047308C-FA25-4F5C-BA46-2535AD1130F7

Q36216823-318D42DC-256F-44AF-99AE-A6F1DB8FD48C

Q36216823-34876BBA-BC46-4295-87A8-37013319B853

Q36216823-3A60E864-1B74-4883-96BD-37EDFFC371E3

Q36216823-3BCF74A5-7927-48D5-8B33-C8BD3D2A8299

Q36216823-45B35666-9C07-4B73-A246-5CB686ACAE70

P304

Q36216823-A961FF84-4F41-4495-8B30-46A3C83D5807

P31

Q36216823-E535EA1F-84A6-434E-948A-F5CE0278FB2F

P356

Q36216823-B6BEDF4B-B669-4214-84AA-9FC70B18CC3D

P433

Q36216823-617DBFDA-4324-42F1-9BBE-CD8B8443AAC1

P478

Q36216823-5B4BB391-B279-4139-9001-739591CCC5C1

P577

Q36216823-CCD0719C-5413-4914-B269-DC866E89097E

P5875

Q36216823-F5D4DB01-FA37-4F27-8BD3-A609594F63AF

P698

Q36216823-37AB8CB1-ED3B-4215-8B6C-05A1187B2668

P932

Q36216823-115E91A1-DBEB-4414-955E-A6D21D12B5D1

P356

P1433

Oncology Letters

P1476

Gastric carcinoma in China: Current status and future perspectives (Review)

@en

P2093

Jin Li

http://www.w3.org/2001/XMLSchema#string

Xiaodong Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin.

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.

P304

407-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL_00000071

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230830818

http://www.w3.org/2001/XMLSchema#string

P698

22966316

http://www.w3.org/2001/XMLSchema#string

P932

3436419

http://www.w3.org/2001/XMLSchema#string